Literature DB >> 7272240

Erythrocyte factors concerned in the inhibition of ALA-D by lead.

T Sakai, S Yanagihara, K Ushio.   

Abstract

Erythrocyte factors are concerned in the inhibition of delta-aminolaevulinic acid dehydratase (ALA-D) by lead at 20 to 100 nM concentrations. The activity of the factors in detected in Hb fractions from Sephadex G-200 gel filtration of erythrocyte supernatant. After gel filtration of erythrocyte supernatant from a lead worker, 50% of lead is found in ALA-D fractions, although the fractions recover from ALA-D inhibition. The recovered activity is reinhibited if the enzyme fraction is preincubated with Hb fraction obtained from the same chromatography. Similarly obtained enzyme from a normal subject is also inhibited when it is preincubated with normal Hb fraction and lead acetate at 20 to 100 nM concentrations. The extent of the inhibition depends on the concentrations of Hb fraction and lead acetate preincubated. Reinhibition of lead worker enzyme with normal Hb fraction may be deleted not only by heating but also by zinc or DTT as well. Hb fraction heated at 60 degrees C for 5 min is also able to induce the lead-inhibition of the activity in ALA-D fraction. Half life of the factors is 26 min at 60 degrees C and 3 min at 80 degrees C.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272240      PMCID: PMC1008885          DOI: 10.1136/oem.38.3.268

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  17 in total

1.  Interaction of zinc and lead on delta-aminolevulinate dehydratase.

Authors:  V N Finelli; D S Klauder; M A Karaffa; H G Petering
Journal:  Biochem Biophys Res Commun       Date:  1975-07-08       Impact factor: 3.575

2.  Studies in lead poisoning. II. Correlation between the ratio of activated to inactivated delta-aminolevulinic acid dehydratase of whole blood and the blood lead level.

Authors:  J L Granick; S Sassa; S Granick; R D Levere; A Kappas
Journal:  Biochem Med       Date:  1973-08

3.  Interactions of lead and glutathione with delta-aminolevulinic acid dehydratase.

Authors:  H J Hapke; E Prigge
Journal:  Arch Toxikol       Date:  1973

4.  [The determination of delta-aminolaevulinic acid dehydratase activity and its diagnostic value].

Authors:  T Haas; W Mache; K H Schaller; K Mache; G Klavis; R Stumpf
Journal:  Int Arch Arbeitsmed       Date:  1972

5.  [Mechanisms of inhibition of erythrocyte delta-aminolevulinic dehydratase activity in human and experimental lead poisoning].

Authors:  C Vergnano; C Cartasegna; V Ardoino
Journal:  Med Lav       Date:  1969 Aug-Sep       Impact factor: 1.275

6.  Delta-aminolevulinic acid dehydratase activity in erythrocytes for the evaluation of lead poisoning.

Authors:  K Nakao; O Wada; Y Yano
Journal:  Clin Chim Acta       Date:  1968-02       Impact factor: 3.786

7.  Delta-aminolevulinic acid dehydrase as a measure of lead exposure.

Authors:  S Hernberg; J Nikkanen; G Mellin; H Lilius
Journal:  Arch Environ Health       Date:  1970-08

8.  Early signs of lead-exposure. A comparative study of laboratory tests.

Authors:  A De Bruin; H Hoolboom
Journal:  Br J Ind Med       Date:  1967-07

9.  [A simple method of determining delta-amino-levulino-dehydratase in the blood. Behavior of the enzyme in lead poisoning].

Authors:  D Bonsignore; P Calissano; C Cartasegna
Journal:  Med Lav       Date:  1965-03       Impact factor: 1.275

10.  Relationship between activation of delta-aminolevulinic acid dehydratase by heating and blood lead level.

Authors:  K Tomokuni; T Kawanishi
Journal:  Arch Toxicol       Date:  1975-11-20       Impact factor: 5.153

View more
  2 in total

1.  Mechanisms of ALA-D inhibition by lead and of its restoration by zinc and dithiothreitol.

Authors:  T Sakai; S Yanagihara; Y Kunugi; K Ushio
Journal:  Br J Ind Med       Date:  1983-02

2.  Effects of fasting on distribution and excretion of lead following long-term lead exposure in rats.

Authors:  M Hayashi; K Yamamoto; M Yoshimura; T Kishimoto; A Shitara
Journal:  Arch Environ Contam Toxicol       Date:  1993-02       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.